Home - Products - Others - Other Targets - Acetyl-Hirudin (55-65) (sulfated)

Acetyl-Hirudin (55-65) (sulfated)

CAS No. 125441-01-2

Acetyl-Hirudin (55-65) (sulfated)( ——— )

Catalog No. M39960 CAS No. 125441-01-2

Acetyl-Hirudin (55-65) (sulfated) is a Acetyl-fragment of Hirudin. Hirudin is a thrombin inhibitor with blood anticoagulant property.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Acetyl-Hirudin (55-65) (sulfated)
  • Note
    Research use only, not for human use.
  • Brief Description
    Acetyl-Hirudin (55-65) (sulfated) is a Acetyl-fragment of Hirudin. Hirudin is a thrombin inhibitor with blood anticoagulant property.
  • Description
    Acetyl-Hirudin (55-65) (sulfated) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    125441-01-2
  • Formula Weight
    1533.57
  • Molecular Formula
    C66H92N12O28S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Birnbaum S, et al. Peptide screening. Current Opinion in Biotechnology, 1992, 3(1): 49-54.
molnova catalog
related products
  • Dehydrotumulosic aci...

    Dehydrotumulosic acid shows anti-inflammatory activity.

  • [Sar1,Val5,Ala8]-Ang...

    [Sar1,Val5,Ala8]-Angiotensin II

  • YX-2-107

    YX-2-107 is a selective and potent CDK6-degrading PROTAC with an IC50 value of 4.4 nM.YX-2-107 inhibits RB phosphorylation and FOXM1 expression in vitro, and inhibits the development of Ph+ ALL in rats.